New diabetes clinical trial: EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial

Published on: August 28, 2020 at 09:30PM
Conditions:   Type 2 Diabetes;   Obesity
Interventions:   Other: Weight Management Program (WMP);   Other: Traditional care;   Drug: Phentermine / Topiramate Extended Release Oral Capsule;   Drug: naltrexone/bupropion extended-release;   Drug: liraglutide 3.0 mg;   Drug: Orlistat
Sponsor:   The Cleveland Clinic
Not yet recruiting
https://ift.tt/2QwdFjd